SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020854
Filing Date
2023-05-11
Accepted
2023-05-11 08:01:26
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ktra-20230331.htm   iXBRL 10-Q 2611866
2 EX-31.1 ktra-ex31_1.htm EX-31 20955
3 EX-31.2 ktra-ex31_2.htm EX-31 20661
4 EX-32.1 ktra-ex32_1.htm EX-32 12174
5 EX-32.2 ktra-ex32_2.htm EX-32 12174
6 GRAPHIC img139662837_0.jpg GRAPHIC 108936
7 GRAPHIC img139662837_1.jpg GRAPHIC 40295
  Complete submission text file 0000950170-23-020854.txt   8802599

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ktra-20230331_lab.xml EX-101.LAB 470920
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ktra-20230331_pre.xml EX-101.PRE 372665
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ktra-20230331.xsd EX-101.SCH 69547
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ktra-20230331_cal.xml EX-101.CAL 22550
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ktra-20230331_def.xml EX-101.DEF 274393
56 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20230331_htm.xml XML 1421899
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 23908928
SIC: 2834 Pharmaceutical Preparations